Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

HIV nucleoside analogues: new adverse effects on mitochondria?

Morris AA, Carr A.

Lancet. 1999 Sep 25;354(9184):1046-7. No abstract available.

PMID:
10509488
2.

[Antiretroviral agents and pregnancy: mitochondrial dysfunction and nucleoside analogs].

Loubeyre-Unique C, Gautier A, Vauzelle-Gardier C, Champart AM, Bavoux F.

Therapie. 2001 May-Jun;56(3):261-6. Review. French.

PMID:
11475805
3.

Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.

Viganò A, Giacomet V.

Antivir Ther. 2005;10 Suppl 2:M53-64. Review. No abstract available.

PMID:
16152706
4.

Prevention of mother-to-child HIV transmission in the context of a comprehensive AIDS agenda in resource-poor countries.

Lackritz EM, Shaffer N, Luo C.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):196-9. Review. No abstract available.

PMID:
12045683
5.

Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.

Claessens YE, Chiche JD, Mira JP, Cariou A.

Crit Care. 2003 Jun;7(3):226-32. Epub 2003 Feb 28. Review.

6.

Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

Senise JF, Castelo A, Martínez M.

AIDS Rev. 2011 Oct-Dec;13(4):198-213. Review.

PMID:
21975356
7.
8.
9.

Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.

Mofenson LM, Munderi P.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):200-15. Review.

PMID:
12045684
10.

Antiretroviral therapy in pregnancy: a focus on safety.

Taylor GP, Low-Beer N.

Drug Saf. 2001;24(9):683-702. Review.

PMID:
11522121
11.

Interruption of materno-fetal transmission.

Mofenson LM, Fowler MG.

AIDS. 1999;13 Suppl A:S205-14. Review. No abstract available.

PMID:
10885777
12.

A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies.

Nolan ML, Greenberg AE, Fowler MG.

AIDS. 2002 Oct 18;16(15):1991-9. Review. No abstract available.

PMID:
12370497
13.

Pediatric HIV infection: recent advances.

Sen S.

Indian Pediatr. 1995 May;32(5):519-27. Review. No abstract available.

PMID:
8613308
14.

Update on mitochondrial toxicity: where are we now?

Walker UA.

J HIV Ther. 2003 May;8(2):32-5. Review.

PMID:
12838162
15.

Preventing neonatal HIV: a review.

Jaspan HB, Garry RF.

Curr HIV Res. 2003 Jul;1(3):321-7. Review.

PMID:
15046256
16.

Paediatric HIV in 2002--a treatable and preventable infection.

Hermione Lyall EG.

J Clin Virol. 2002 Aug;25(2):107-19. Review. No abstract available.

PMID:
12367645
17.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
18.

HIV-1 drug resistance and mother-to-child transmission.

Morris L, Pillay C, Gray G, McIntyre J.

SADJ. 2001 Dec;56(12):614-6. Review.

PMID:
11887450
19.

Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).

Pujari S, Patel A, Joshi SR, Gangakhedkar R, Kumarasamy N, Gupta SB; Expert Panel 2008..

J Assoc Physicians India. 2008 May;56:339-48, 353-71. Review. No abstract available.

PMID:
18700643
20.

Nucleoside analogues in 2008.

Warwick Z, Churchill D.

J HIV Ther. 2008 Mar;13(1):3-8. Review. No abstract available.

PMID:
18953267

Supplemental Content

Support Center